doi: 10.1053/J.GASTRO.2015.02.006 181 KanagarathamCel AnsariYSLewisOLOettgenHC
Desire for a different approach motivates some switches even when tirzepatide is working
Chen X, Zhao P, Wang W, Guo L, Pan Q
The researchers found that among adults who were overweight or obese who completed the 20-week run-in period with subcutaneous semaglutide, maintaining treatment with semaglutide resulted in continued weight loss over the following 48 weeks compared to switching to placebo
Anticonvulsants (Valproic Acid) Treatment with valproic acid, phenobarbital, phenytoin, and carbamazepine reduces blood levels of carnitine [1][71][72][73]
Adems, dado que los datos provienen de la Administracin de Veteranos [de las Fuerzas Armadas de Estados Unidos], estn fuertemente sesgados hacia hombres mayores y blancos